Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI (NASDAQ:SHPH)

Core Insights - Artificial intelligence has significantly impacted various industries, with drug discovery being one of the most challenging areas for its application [1] Industry Summary - Drug discovery remains a complex field where molecules exhibit unpredictable behaviors, making it difficult for algorithms to accurately predict outcomes [1]